PA
LCTX icon

Parallel Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Parallel Advisors’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-142
Closed – – 2532
2019
Q4 		$0 Hold
142
– – ﹤0.01% 2457
2019
Q3 		$0 Hold
142
– – ﹤0.01% 2454
2019
Q2 		$0 Sell
142
-653
-82% -$753 ﹤0.01% 2383
2019
Q1 		$1K Buy
795
+142
+22% +$177 ﹤0.01% 2192
2018
Q4 		$0 Buy
653
+340
+109% +$521 ﹤0.01% 2211
2018
Q3 		$1K Hold
313
– – ﹤0.01% 2144
2018
Q2 		$0 Buy
+313
New +$630 ﹤0.01% 2156

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return